Sign in

Tom Clarke

Chief Growth Initiatives Officer at NIKE
Executive

About Tom Clarke

Tom (Dr. Thomas) Clarke is a 45-year Nike veteran appointed Chief Growth Initiatives Officer in May 2025 after serving as strategic advisor to the CEO since 2023, reflecting deep operating, product, and innovation expertise across the brand’s history . He joined Nike in 1980 as Director of Biomechanics Research, later holding roles including Director of R&D; VP, Product; VP, Marketing; GM, Nike Brand; VP Footwear & Apparel; and President & COO from 1994–2000; he subsequently led Nike’s advanced innovation for 11 years as President of Innovation . Nike’s executive pay programs emphasize pay-for-performance: the fiscal 2025 annual cash plan (PSP) and fiscal 2023–2025 PSU awards paid out at 0%, tying incentives to Adjusted Revenue, Adjusted EBIT, and three-year Relative TSR with a cap when absolute TSR is negative .

Past Roles

OrganizationRoleYearsStrategic Impact
NikeDirector of Biomechanics Research1980 Built foundational biomechanics capability to inform product performance
NikeDirector of Research & DevelopmentNot disclosed Advanced product innovation in footwear/apparel
NikeVP, Product; VP, Marketing; GM, Nike BrandNot disclosed Drove product creation and brand positioning
NikeVP, Footwear & Apparel (first senior leadership role)Not disclosed Led category leadership across core lines
NikePresident & Chief Operating Officer1994–2000 Enterprise execution and operating performance
NikePresident of Innovation11 years (dates not disclosed) Led advanced innovation across footwear, apparel, accessories
NikeStrategic Advisor to the CEO2023–2025 Senior counsel on brand, product, and innovation strategy
NikeChief Growth Initiatives Officer2025–present Driving growth initiatives under the “Win Now” plan

External Roles

OrganizationRoleYears
NIKE, Inc.Board member (prior service)Not disclosed
Newell RubbermaidBoard member (prior service)Not disclosed
Starwood HotelsBoard member (prior service)Not disclosed

Performance Compensation

Plan/InstrumentMetricWeightingTarget/GoalActual/ResultPayoutVesting
Annual Cash Incentive (PSP)Adjusted Revenue50% Targets set below FY24 given environment; threshold/maximum symmetric around target (rev) FY25 Adjusted Revenue $46.4B → 0% earnout 0% 1-year performance period
Annual Cash Incentive (PSP)Adjusted EBIT50% Targets set below FY24; maximum non-equidistant to add stretch (EBIT) FY25 Adjusted EBIT $3.5B → 0% earnout 0% 1-year performance period
Stock Incentive Plan (SIP) – PSUsRelative TSR (3-year) with People & Planet modifier50% of LT award mix 55th percentile earns 100%; below 25th percentile earns 0%; capped at 100% if absolute TSR is negative; modifier ±20 pts on earnout FY23–FY25 PSUs earned 0% 0% Typically 3-year performance period
Stock Incentive Plan (SIP) – OptionsStock price appreciation35% of LT award mix N/A (value only if stock appreciates) Options had no intrinsic value at FY25 year-end (example for NEOs) N/A Generally vests in 4 equal annual installments
Stock Incentive Plan (SIP) – RSUsStock price15% of LT award mix N/AN/AN/AGenerally vests in 3–4 equal annual installments

Note: The table summarizes Nike’s disclosed executive incentive frameworks and outcomes; Tom Clarke’s individual grant values and payouts are not disclosed in the proxy. Program features (metrics, weights, payout caps) demonstrate strong pay-for-performance linkage .

Equity Ownership & Alignment

  • Robust stock ownership guidelines apply to executives; awards vest over time to promote long-term performance and retention; hedging and short sales are prohibited; no dividend equivalents on PSUs/RSUs until vesting .
  • Double-trigger change-in-control treatment for stock-based awards; no option repricing without shareholder approval; clawback policies apply to incentive compensation .

Beneficial ownership, pledged shares, and option exercisability for Tom Clarke are not disclosed in the proxy and no Form 4 transactions were retrieved in the documents scanned; therefore, these data points are not available from company filings above.

Employment Terms

TermProvisionSource
Role and Effective DateAppointed Chief Growth Initiatives Officer; effective May 5, 2025
Tenure/Start at NikeJoined in 1980; 45-year veteran
Change-in-ControlDouble-trigger acceleration for stock-based awards; no cash-based CIC benefits; no excise tax gross-ups
ClawbackAwards subject to NIKE clawback policy and applicable regulations; no repricing without shareholder approval
Non-compete/SeveranceCompany maintains non-compete agreements for certain executives (example disclosed for a different NEO); Tom Clarke’s specific terms not disclosed

Expertise & Qualifications

  • Technical and innovation leadership: biomechanics research foundation, R&D, product creation, and 11 years leading advanced innovation across footwear/apparel/accessories .
  • Enterprise operating experience: President & COO (1994–2000), GM Nike Brand, senior leadership across product and marketing .
  • Governance exposure: prior board service at NIKE, Newell Rubbermaid, and Starwood Hotels .

Investment Implications

  • Alignment and retention: Clarke’s appointment to Chief Growth Initiatives Officer and long-tenure suggest high strategic alignment and low immediate retention risk; incentive frameworks with zero PSP and PSU payouts in FY25/23–25 underscore strict pay-for-performance linkage amid turnaround execution .
  • Governance quality: Double-trigger CIC treatment, robust clawbacks, prohibition on hedging/short sales, and no option repricing or excise tax gross-ups reduce governance red flags; stock ownership guidelines support long-term alignment .
  • Execution risk: Clarke’s remit centers on growth initiatives within Nike’s “Win Now” plan, leveraging deep innovation and operating experience; incentives linked to Adjusted Revenue, Adjusted EBIT, and Relative TSR tie his success to tangible financial and shareholder outcomes .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%